Lyell Immunopharma (LYEL) Short Interest Ratio & Short Volume

Lyell Immunopharma logo
$13.35 -1.30 (-8.89%)
As of 10:49 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Lyell Immunopharma Short Interest Overview

As of October 30, 2026, Lyell Immunopharma (LYEL) had a short interest of 1.41 million shares sold short, representing 6.11% of the public float. This marks a 0.81% increase in short interest since the prior report. The short interest ratio (days to cover) is 10.4, meaning it would take 10.4 days of the average trading volume of 142,973 shares to cover all short positions.

Current Short Interest
1,409,625 shares
Previous Short Interest
1,398,232 shares
Change Vs. Previous Report
0.81%
Dollar Volume Sold Short
$15.56 million
Short Interest Ratio
10.4 Days to Cover
Last Record Date
October 30, 2026
Outstanding Shares
24,590,000 shares
Short Percent of Float
6.11%
Today's Trading Volume
35,444 shares
Average Trading Volume
142,973 shares
Today's Volume Vs. Average
25%
Short Selling Lyell Immunopharma?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Lyell Immunopharma and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

LYEL Short Interest Over Time

LYEL Days to Cover Over Time

LYEL Percentage of Float Shorted Over Time

Lyell Immunopharma Tesla Short Interest History & Recent Changes

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/30/20261,409,625 shares $15.56 million +0.8%6.1%10.43 $11.04
10/15/20261,398,232 shares $11.45 million +10.7%6.1%7.85 $8.19
9/30/20261,263,394 shares $12.37 million +6.4%5.5%7.4 $9.79
9/15/20261,187,902 shares $12.96 million +5.0%5.2%12.08 $10.91
8/31/20261,131,628 shares $16.20 million -1.7%4.9%8.89 $14.32
8/14/20261,151,707 shares $16.07 million -6.5%5.0%6.26 $13.95
7/31/20261,231,583 shares $15.94 million +0.9%5.4%8.66 $12.94
7/15/20261,220,497 shares $17.40 million -0.2%5.3%6.7 $14.26
6/30/20261,223,220 shares $17.19 million -7.1%5.6%3.44 $14.05
6/15/20261,316,562 shares $17.84 million -2.7%6.0%9.62 $13.55
5/29/20261,353,275 shares $23.45 million +1.0%6.2%16.21 $17.33
5/15/20261,340,406 shares $24.02 million -0.3%6.1%23.25 $17.92
4/30/20261,344,189 shares $26.52 million +8.9%6.1%18.78 $19.73
4/15/20261,234,370 shares $29.43 million +8.4%5.6%12.04 $23.84
3/31/20261,138,296 shares $22.83 million +21.1%5.0%12.78 $20.06
3/13/2026940,269 shares $19.98 million +15.3%5.2%8.59 $21.25
2/27/2026815,248 shares $19.57 million +37.7%4.9%7.63 $24.00
2/13/2026592,027 shares $15.30 million +13.6%2.7%6.28 $25.84
1/30/2026521,115 shares $12.51 million +28.0%3.2%6.09 $24.00
1/15/2026407,278 shares $9.34 million +69.2%2.5%3.96 $22.93
12/31/2025240,730 shares $7.41 million +46.4%1.5%1.58 $30.78
12/15/2025164,482 shares $5.33 million +1.7%1.0%2.44 $32.40
11/28/2025161,792 shares $5.24 million -0.8%1.0%3.35 $32.40
11/14/2025163,125 shares $2.76 million -1.9%1.0%5.91 $16.93
10/31/2025166,193 shares $2.77 million -9.6%1.1%6.54 $16.66
10/15/2025183,900 shares $3.20 million -21.1%2.1%3.5 $17.38
9/30/2025233,100 shares $3.79 million +43.4%2.7%4.4 $16.24
9/15/2025162,600 shares $2.13 million +11.6%1.9%2.1 $13.13
8/31/2025145,700 shares $1.61 million +9.6%1.7%1.7 $11.08
8/15/2025133,000 shares $1.41 million -29.3%2.4%1 $10.58
7/31/2025188,200 shares $2.22 million -22.8%3.3%1.3 $11.81
7/15/2025243,800 shares $2.22 million -6.5%3.6%1.9 $9.10
6/30/2025260,600 shares $2.30 million -26.7%4.0%2 $8.84
6/15/2025355,300 shares $3.46 million -33.2%5.6%3.4 $9.74
5/31/2025531,500 shares $0.00 -94.5%8.8%5.7 $0.00
5/15/20259,710,000 shares $3.90 million +71.6%8.1%12.6 $0.40
4/30/20255,660,000 shares $2.69 million +0.4%4.5%5.9 $0.48
4/15/20255,640,000 shares $2.59 million -1.2%4.5%5.8 $0.46
3/31/20255,710,000 shares $3.07 million -4.5%4.6%5.7 $0.54
3/15/20255,980,000 shares $3.50 million -26.1%4.8%5.5 $0.59
Trump’s EO to send this $5 stock ripping higher…? (Ad)

President Trump's December executive order declared space a national security and economic priority, fueling a race among SpaceX, Blue Origin, and others to build massive satellite constellations. One tiny firm holds the patented tech required to transmit satellite data to Earth at scale - and it reportedly powers SpaceX's most profitable division. Shares trade for under 5 dollars. Former JPMorgan wealth manager Ross Givens says it's the most uniquely positioned stock he's seen in 20 years of trading.tc pixel

Get the full free report on this overlooked space stock now
2/28/20258,090,000 shares $5.75 million -16.2%6.5%7 $0.71
2/15/20259,650,000 shares $5.89 million -16.3%7.7%7.6 $0.61
1/31/202511,530,000 shares $6.81 million -7.0%7.6%9.4 $0.59
1/15/202512,400,000 shares $7.41 million +0.7%8.2%8.2 $0.60
12/31/202412,310,000 shares $7.88 million +12.0%8.5%8.5 $0.64
12/15/202410,990,000 shares $7.41 million +16.3%7.6%7.7 $0.67
11/30/20249,450,000 shares $8.93 million -1.6%7.2%7.3 $0.95
11/15/20249,600,000 shares $10.56 million -13.8%7.7%7.7 $1.10
10/31/202411,140,000 shares $10.70 million +3.5%8.9%10.3 $0.96
10/15/202410,760,000 shares $12.59 million +0.9%9.4%17.1 $1.17
9/30/202410,660,000 shares $14.71 million -19.4%9.4%16 $1.38
9/15/202413,220,000 shares $16.26 million -3.9%11.6%13.8 $1.23
8/31/202413,760,000 shares $19.95 million -8.5%12.1%14.6 $1.45
8/15/202415,030,000 shares $18.86 million -7.9%13.3%15.9 $1.26
7/31/202416,320,000 shares $26.28 million +1.2%13.6%16.9 $1.61
7/15/202416,130,000 shares $27.74 million -10.0%13.6%16.6 $1.72
6/30/202417,920,000 shares $25.98 million -25.8%15.1%16.9 $1.45
6/15/202424,150,000 shares $56.99 million +19.6%20.4%30.6 $2.36
5/31/202420,200,000 shares $55.95 million +0.5%17.1%25.2 $2.77
5/15/202420,100,000 shares $52.46 million +0.7%17.0%23.3 $2.61
4/30/202419,970,000 shares $43.33 million +9.5%16.9%22.3 $2.17
4/15/202418,230,000 shares $43.75 million +0.7%15.5%19.8 $2.40
3/31/202418,100,000 shares $40.36 million +74.4%15.5%18.8 $2.23
3/15/202410,380,000 shares $22.42 million -5.2%8.9%10.3 $2.16
2/29/202410,950,000 shares $31.97 million -39.6%9.4%8.9 $2.92
2/15/202418,130,000 shares $34.45 million +67.3%15.7%14.5 $1.90
1/31/202410,840,000 shares $19.84 million -30.6%9.4%8.2 $1.83
1/15/202415,620,000 shares $34.68 million +4.4%12.7%11.8 $2.22
12/31/202314,960,000 shares $29.02 million -13.2%12.1%12.2 $1.94
12/15/202317,240,000 shares $33.10 million -0.6%14.0%15.3 $1.92
11/30/202317,340,000 shares $30.00 million -2.3%14.1%18.8 $1.73
11/15/202317,740,000 shares $36.37 million -7.6%14.4%20.3 $2.05
10/31/202319,200,000 shares $31.78 million -7.3%15.8%25.1 $1.66
10/15/202320,720,000 shares $33.98 million -2.3%17.1%29.2 $1.64
9/30/202321,210,000 shares $31.18 million +1.3%17.5%30 $1.47
9/15/202320,930,000 shares $35.37 million -5.2%17.2%28.3 $1.69
8/31/202322,070,000 shares $52.75 million -3.7%18.3%24.3 $2.39
8/15/202322,910,000 shares $52.46 million -2.5%19.0%23 $2.29
7/31/202323,500,000 shares $67.92 million +1.5%19.6%22 $2.89
7/15/202323,160,000 shares $67.86 million -1.2%19.3%20.9 $2.93
6/30/202323,450,000 shares $74.57 million +3.9%19.6%20.8 $3.18
6/15/202322,580,000 shares $87.16 million +4.9%18.9%18.7 $3.86
5/31/202321,530,000 shares $68.68 million +2.8%18.0%20.1 $3.19
5/15/202320,950,000 shares $63.06 million +3.2%17.5%19.8 $3.01
4/30/202320,300,000 shares $41.21 million -0.7%17.0%20.1 $2.03
4/15/202320,450,000 shares $48.26 million -1.8%17.1%20.9 $2.36
3/31/202320,830,000 shares $49.16 million +1.3%17.4%20.2 $2.36
3/15/202320,560,000 shares $45.03 million +14.2%17.2%19.6 $2.19
2/28/202318,010,000 shares $38.72 million +5.4%15.1%16.2 $2.15
2/15/202317,080,000 shares $42.70 million -2.1%14.3%15.7 $2.50
Top Trader Reveals Stunning Black Friday Deal (Ad)

Others paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Trading's Thomas Wood calls it one of the firm's most powerful proprietary trading indicators, and says the company has never run a deal like this before. There are no strings attached, just a steep Black Friday discount on a tool built for traders.tc pixel

Get the Snapback Indicator for just $7 in the Black Friday sale today.
1/31/202317,440,000 shares $57.03 million -2.9%14.6%15.2 $3.27
1/15/202317,960,000 shares $58.01 million -9.4%15.0%15.5 $3.23
12/30/202219,820,000 shares $68.78 million +15.8%20.3%18 $3.47
12/15/202217,110,000 shares $56.12 million -2.0%17.5%16.1 $3.28
11/30/202217,450,000 shares $73.46 million -5.7%22.0%15.3 $4.21
11/15/202218,510,000 shares $85.15 million -2.5%23.4%16.5 $4.60
10/31/202218,990,000 shares $111.66 million -1.1%23.4%18.6 $5.88
10/15/202219,200,000 shares $125.57 million +5.1%23.6%18.6 $6.54
9/30/202218,270,000 shares $133.92 million +19.3%22.5%18.6 $7.33
9/15/202215,320,000 shares $121.95 million +7.0%19.1%14.7 $7.96
8/31/202214,320,000 shares $95.94 million -7.2%18.1%15.6 $6.70
8/15/202215,430,000 shares $116.03 million -4.6%19.5%17.1 $7.52
7/31/202216,180,000 shares $90.12 million -4.9%25.4%17.1 $5.57
7/15/202217,010,000 shares $100.36 million -2.4%26.7%19.1 $5.90
6/30/202217,430,000 shares $113.64 million +6.9%27.4%19.3 $6.52
6/15/202216,310,000 shares $77.15 million +1.8%25.6%17.9 $4.73
5/31/202216,030,000 shares $66.36 million +5.6%25.4%13 $4.14
5/15/202215,180,000 shares $60.57 million -2.9%24.1%11.9 $3.99
4/30/202215,640,000 shares $80.23 million -6.0%26.4%12.3 $5.13
4/15/202216,630,000 shares $89.64 million +5.3%28.1%13 $5.39
3/31/202215,800,000 shares $79.79 million +29.7%26.7%12.3 $5.05
3/15/202212,180,000 shares $73.20 million +21.7%21.0%9 $6.01
2/28/202210,010,000 shares $72.47 million +6.0%17.3%11.3 $7.24
2/15/20229,440,000 shares $64.38 million +9.6%16.4%12.4 $6.82
1/31/20228,610,000 shares $48.90 million +2.7%14.9%12.9 $5.68
1/15/20228,380,000 shares $50.62 million +10.1%14.5%14.8 $6.04
12/31/20217,610,000 shares $58.90 million +22.4%13.2%15.1 $7.74
12/15/20216,220,000 shares $55.98 million +17.4%10.8%13 $9.00
11/30/20215,300,000 shares $50.62 million +7.1%9.9%12.1 $9.55

LYEL Short Interest - Frequently Asked Questions

Short interest is the volume of Lyell Immunopharma shares that have been sold short but have not yet been closed out or covered. As of October 30th, traders have sold 1,409,625 shares of LYEL short. 6.11% of Lyell Immunopharma's shares are currently sold short. Learn More on Lyell Immunopharma's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. LYEL shares currently have a short interest ratio of 10.4. Learn More on Lyell Immunopharma's short interest ratio.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.11% of Lyell Immunopharma's floating shares are currently sold short.

Lyell Immunopharma saw an increase in short interest since the prior report. As of October 30th, there was short interest totaling 1,409,625 shares, an increase of 0.8% from the previous total of 1,398,232 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

6.11% of Lyell Immunopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Lyell Immunopharma: Damora Therapeutics, Inc. Common Stock (7.61%), Ascentage Pharma Group International - Unsponsored ADR (0.01%), AnaptysBio, Inc. (24.66%), Taysha Gene Therapies, Inc. (17.00%), Kardigan, Inc. (6.09%), Alvotech (2.05%), Inhibrx Biosciences, Inc. (28.17%), MannKind Corporation (8.37%), Tyra Biosciences, Inc. (18.96%), Nektar Therapeutics (20.33%),

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($77.66 billion), Invesco QQQ ($57.17 billion), iShares Russell 2000 ETF ($21.91 billion), SPDR S&P Biotech ETF ($10.53 billion), Union Pacific Corporation ($9.26 billion), iShares iBoxx $ High Yield Corporate Bond ETF ($9.05 billion), Nebius Group N.V. ($7.85 billion), iShares 20+ Year Treasury Bond ETF ($7.81 billion), Moderna, Inc. ($7.36 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.20 billion). View all of the most shorted stocks.

Short selling LYEL is an investing strategy that aims to generate trading profit from Lyell Immunopharma as its price is falling. LYEL shares are trading up $0.35 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Lyell Immunopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of LYEL, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including LYEL, twice per month. The most recent reporting period available is October, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like LYEL:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.



Short interest data for NASDAQ:LYEL is sourced from the Financial Industry Regulatory Authority (FINRA), with the most recent report published on 11/10/2026. FINRA publishes updated short interest twice a month.
From Our Partners